Axial Biotherapeutics Obtains $19,000,000 Series A Funding
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b1bdc4fb-dcfd-41c5-bc6b-d690060ed32c - Date
12/1/2016 - Company Name
Axial Biotherapeutics - Mailing Address
800 Boylston St. 15th Floor Boston, MA 02199 USA - Company Description
Axial Biotherapeutics is a biopharmaceutical company harnessing the link between the human gut microbiome and Central Nervous System to develop a new class of therapeutics to improve the quality of life for people with CNS diseases and disorders. - Website
http://www.axialbiotherapeutics.com - Transaction Type
Venture Equity - Transaction Amount
$19,000,000 - Transaction Round
Series A - Proceeds Purposes
Proceeds purposes were not disclosed. - M&A Terms
- Venture Investor
Longwood Fund - Venture Investor
Domain Associates - Venture Investor
Heritage Capital
